英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

unpack    音标拼音: [ənp'æk]
vt. 卸下,打开,解除
vi. 打开包裹

卸下,打开,解除打开包裹

unpack
解聚; 拆包; 还原; 拆开; 卸; 分开; 扩张; 松展; 析( 取)

unpack
拆开

unpack
v 1: remove from its packing; "unpack the presents" [synonym:
{unpack}, {take out}] [ant: {pack}]

Unpack \Un*pack"\, v. t. [1st pref. un- pack.]
[1913 Webster]
1. To separate and remove, as things packed; to open and
remove the contents of; as, to unpack a trunk.
[1913 Webster]

2. To relieve of a pack or burden. [R.] --Shak.
[1913 Webster]


请选择你想看的字典辞典:
单词字典翻译
unpack查看 unpack 在百度字典中的解释百度英翻中〔查看〕
unpack查看 unpack 在Google字典中的解释Google英翻中〔查看〕
unpack查看 unpack 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Orna Therapeutics - Ahead of the Curve
    Our field-defining engineered circular RNA (oRNA ®) has unmatched advantages compared to linear RNA, and our groundbreaking LNP delivery to sites other than the liver has led the world in unlocking the treatment of a far greater span of diseases than previously addressable
  • in Situ CAR Therapy Using oRNA Lipid Nanoparticles Regresses Tumors In Vivo
    ll-tolerated, robust and reproducible efficacy across multiple PBMC donors Tumor regression was dose-dependent oRNA-enabled isCAR therapies promise a transient, re-dosable and scalable immune
  • Our Pipeline - Orna Therapeutics
    Orna’s in vivo CAR platform (panCAR™) combines oRNA ® technology with our proprietary LNPs to create therapies that can modify immune cells within a patient, no lymphodepletion or waiting required
  • Orna Therapeutics Announces Strategic Acquisition of ReNAgade . . .
    WATERTOWN, Mass and CAMBRIDGE, Mass , May 23, 2024 – Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNA ®), today announced its acquisition of ReNAgade Therapeutics, a pioneer in unlocking the potential of RNA therapeutics that demonstrated
  • Our Approach Strategy - Orna Therapeutics
    We are developing the leading circular RNA technology platform (oRNA ®) and unprecedented lipid nanoparticle (LNP) delivery solutions – significantly expanding the therapeutic possibilities of circular RNA and pioneering the next chapter of safe and effective in vivo therapies
  • Orna Therapeutics Announces Presentation at the American Society of . . .
    WATERTOWN, Mass , May 5, 2025 – Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat autoimmune and oncology diseases, today announced an upcoming presentation at the 28 th American Society of Gene Cell Therapy (ASGCT) Annual Meeting being held May 13-17, 2025, in New Orleans, Louisiana
  • Orna Therapeutics Presents New Preclinical Data Supporting its in vivo . . .
    In today’s presentation, Orna will showcase preclinical data demonstrating the potential of its in vivo panCAR therapy, enabled by its proprietary circular (oRNA®) technology and best-in-class lipid nanoparticle (LNP) delivery system to achieve robust and sustained B cell depletion in both humanized mouse models and non-human primates across
  • About Us - Orna Therapeutics
    Our team has the experience to take our comprehensive oRNA ® and LNP platform technologies into the future to improve upon existing therapies across oncology, autoimmune and other indications
  • Orna Therapeutics Presents Data Highlighting Novel panCAR™ Approach to . . .
    –A single dose of Orna’s anti-CD20 panCAR™ resulted in a significant reduction in non-human primate (NHP) B cells, with sustained depletion observed 7 days after dosing– –Approach offers a transient and scalable immune cell therapy without the need for lymphodepletion–
  • Simnova and Orna Therapeutics Collaborate to Advance Ornas Next . . .
    ORN-101, Orna’s lead program, is an in situ CAR therapy designed to modify a patient’s immune cells inside their body Comprising an oRNA molecule packaged inside a proprietary LNP, this easily redosable format could avoid patient lymphodepletion and allow for reliable dose control, overcoming barriers of existing ex vivo CAR-T therapies





中文字典-英文字典  2005-2009